0001127602-22-000457.txt : 20220104 0001127602-22-000457.hdr.sgml : 20220104 20220104161953 ACCESSION NUMBER: 0001127602-22-000457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McMillan Wayde D. CENTRAL INDEX KEY: 0001768648 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 22506237 MAIL ADDRESS: STREET 1: C/O INSULET CORPORATION STREET 2: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-12-31 0001145197 INSULET CORP PODD 0001768648 McMillan Wayde D. C/O INSULET CORPORATION 100 NAGOG PARK ACTON MA 01720 1 EVP, CFO Common Stock 2021-12-31 4 S 0 193 266.37 D 21740 D Common Stock 2021-12-31 4 S 0 400 267.82 D 21340 D Common Stock 2021-12-31 4 S 0 500 268.88 D 20840 D Common Stock 2021-12-31 4 S 0 672 270.19 D 20168 D Common Stock 2021-12-31 4 S 0 90 271.23 D 20078 D The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $266.04 to $266.54. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $267.45 to $268.11. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $268.47 to $269.36. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $269.86 to $270.55. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. /s/ John W. Kapples, attorney-in-fact 2022-01-04